• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项针对住院患者中复杂性皮肤和软组织感染的前瞻性、多中心、观察性研究:临床特征、治疗方法和结局。

A prospective, multicenter, observational study of complicated skin and soft tissue infections in hospitalized patients: clinical characteristics, medical treatment, and outcomes.

机构信息

VA Puget Sound Health Care System & University of Washington, Seattle, WA, USA.

出版信息

BMC Infect Dis. 2012 Sep 25;12:227. doi: 10.1186/1471-2334-12-227.

DOI:10.1186/1471-2334-12-227
PMID:23009247
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3524462/
Abstract

BACKGROUND

Complicated skin and soft tissue infections (cSSTIs) occur frequently, but limited data do not allow any consensus on an optimal treatment strategy. We designed this prospective, multicenter, observational study to to explore the current epidemiology, treatment, and resulting clinical outcomes of cSSTIs to help develop strategies to potentially improve outcomes.

METHODS

From June 2008 to December 2009 we enrolled a pre-specified number of adults treated in 56 U.S. hospitals with intravenous antibiotic(s) for any of the following cSSTIs: diabetic foot infection (DFI); surgical site infection (SSI); deep soft tissue abscess (DSTA); or, cellulitis. Investigators treated all patients per their usual practice during the study and collected data on a standardized form.

RESULTS

We enrolled 1,033 patients (DFI 27%; SSI 32%; DSTA 14%; cellulitis 27%; mean age 54 years; 54% male), of which 74% had healthcare-associated risk factors. At presentation, 89% of patients received initial empiric therapy with intravenous antibiotics; ~20% of these patients had this empiric regimen changed or discontinued based on culture and sensitivity results. Vancomycin was the most frequently used initial intravenous antibiotic, ordered in 61% of cases. During their stay 44% of patients underwent a surgical procedure related to the study infection, usually incision and drainage or debridement. The mean length of stay was 7.1 days, ranging from 5.8 (DSTA) to 8.1 (SSI).

CONCLUSION

Our findings from this large prospective observational study that characterized patients with cSSTIs from diverse US inpatient populations provide useful information on the current epidemiology, clinical management practices and outcomes of this common infection.

摘要

背景

复杂皮肤和软组织感染(cSSTIs)频繁发生,但有限的数据无法就最佳治疗策略达成共识。我们设计了这项前瞻性、多中心、观察性研究,以探索 cSSTIs 的当前流行病学、治疗方法和临床结果,以帮助制定策略,可能改善治疗结果。

方法

我们从 2008 年 6 月至 2009 年 12 月,在 56 家美国医院招募了经静脉用抗生素治疗的规定数量的成年患者,这些患者患有以下任何一种 cSSTIs:糖尿病足感染(DFI);手术部位感染(SSI);深部软组织脓肿(DSTA);或蜂窝织炎。研究者根据研究期间的常规做法治疗所有患者,并使用标准化表格收集数据。

结果

我们共招募了 1033 名患者(DFI 占 27%;SSI 占 32%;DSTA 占 14%;蜂窝织炎占 27%;平均年龄 54 岁;54%为男性),其中 74%有与医疗保健相关的危险因素。在就诊时,89%的患者接受了初始经验性静脉内抗生素治疗;约 20%的患者根据培养和药敏结果改变或停止了初始经验性治疗方案。万古霉素是最常使用的初始静脉内抗生素,61%的患者使用了该药。在住院期间,44%的患者接受了与研究感染相关的手术,通常是切开引流或清创术。平均住院时间为 7.1 天,范围为 5.8(DSTA)至 8.1(SSI)天。

结论

我们从这项大型前瞻性观察性研究中得出的结果,描述了来自美国不同住院患者人群的 cSSTIs 患者的情况,为这种常见感染的当前流行病学、临床管理实践和结果提供了有用的信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3039/3524462/3eedefe87a90/1471-2334-12-227-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3039/3524462/fe54b2c30357/1471-2334-12-227-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3039/3524462/3eedefe87a90/1471-2334-12-227-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3039/3524462/fe54b2c30357/1471-2334-12-227-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3039/3524462/3eedefe87a90/1471-2334-12-227-2.jpg

相似文献

1
A prospective, multicenter, observational study of complicated skin and soft tissue infections in hospitalized patients: clinical characteristics, medical treatment, and outcomes.一项针对住院患者中复杂性皮肤和软组织感染的前瞻性、多中心、观察性研究:临床特征、治疗方法和结局。
BMC Infect Dis. 2012 Sep 25;12:227. doi: 10.1186/1471-2334-12-227.
2
Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010-2011): assessment of clinical practice patterns and real-life effectiveness of antibiotics from the REACH study.欧洲复杂皮肤和软组织感染住院患者的当前管理(2010-2011 年):来自 REACH 研究的临床实践模式评估和抗生素的实际效果。
Clin Microbiol Infect. 2013 Sep;19(9):E377-85. doi: 10.1111/1469-0691.12235. Epub 2013 May 10.
3
Early response to antibiotic treatment in European patients hospitalized with complicated skin and soft tissue infections: analysis of the REACH study.欧洲复杂皮肤及软组织感染住院患者对抗生素治疗的早期反应:REACH研究分析
BMC Infect Dis. 2015 Feb 19;15:78. doi: 10.1186/s12879-015-0822-2.
4
Surgical site infections: does inadequate antibiotic therapy affect patient outcomes?手术部位感染:抗生素治疗不足会影响患者预后吗?
Surg Infect (Larchmt). 2009 Aug;10(4):323-31. doi: 10.1089/sur.2008.053.
5
Pan-European early switch/early discharge opportunities exist for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections.欧洲各地为患有耐甲氧西林金黄色葡萄球菌复杂性皮肤和软组织感染的住院患者提供了早期转换/早期出院的机会。
Clin Microbiol Infect. 2014 Oct;20(10):993-1000. doi: 10.1111/1469-0691.12632. Epub 2014 May 15.
6
Inappropriate initial antibiotic treatment for complicated skin and soft tissue infections in hospitalized patients: incidence and associated factors.住院患者复杂皮肤及软组织感染的初始抗生素不恰当治疗:发生率及相关因素
Diagn Microbiol Infect Dis. 2014 Jun;79(2):273-9. doi: 10.1016/j.diagmicrobio.2014.02.011. Epub 2014 Feb 24.
7
Economic outcomes of inappropriate initial antibiotic treatment for complicated skin and soft tissue infections: a multicenter prospective observational study.复杂皮肤及软组织感染初始抗生素治疗不当的经济后果:一项多中心前瞻性观察研究
Diagn Microbiol Infect Dis. 2014 Jun;79(2):266-72. doi: 10.1016/j.diagmicrobio.2014.02.013. Epub 2014 Feb 24.
8
Epidemiology and outcomes of complicated skin and soft tissue infections in hospitalized patients.住院患者中复杂性皮肤和软组织感染的流行病学和结局。
J Clin Microbiol. 2012 Feb;50(2):238-45. doi: 10.1128/JCM.05817-11. Epub 2011 Nov 23.
9
Tigecycline in the Treatment of Patients with Necrotizing Skin and Soft Tissue Infections Due to Multiresistant Bacteria.替加环素治疗多重耐药菌所致坏死性皮肤及软组织感染患者
Surg Infect (Larchmt). 2015 Oct;16(5):618-25. doi: 10.1089/sur.2014.089. Epub 2015 Jun 26.
10
Clinical efficacy of piperacillin/tazobactam in the treatment of complicated skin and soft tissue infections.哌拉西林/他唑巴坦治疗复杂性皮肤及软组织感染的临床疗效
Expert Opin Pharmacother. 2017 Jul;18(10):1027-1034. doi: 10.1080/14656566.2017.1341491. Epub 2017 Jun 23.

引用本文的文献

1
Role of Biomarkers in Diabetic Foot Osteomyelitis.生物标志物在糖尿病足骨髓炎中的作用
J Orthop Case Rep. 2025 Sep;15(9):342-347. doi: 10.13107/jocr.2025.v15.i09.6120.
2
Purulent Skin and Soft Tissue Infections, Challenging the Practice of Incision and Drainage: A Scoping Review.脓性皮肤和软组织感染:对切开引流实践的挑战——一项范围综述
Nurs Res Pract. 2023 Oct 6;2023:5849141. doi: 10.1155/2023/5849141. eCollection 2023.
3
A Review of CRISPR-Based Advances in Dermatological Diseases.基于 CRISPR 的皮肤病学进展综述。

本文引用的文献

1
Randomized, double-blind, phase II, multicenter study evaluating the safety/tolerability and efficacy of JNJ-Q2, a novel fluoroquinolone, compared with linezolid for treatment of acute bacterial skin and skin structure infection.一项评价 JNJ-Q2(一种新型氟喹诺酮)与利奈唑胺治疗急性细菌性皮肤和皮肤结构感染的安全性/耐受性和疗效的随机、双盲、II 期、多中心研究。
Antimicrob Agents Chemother. 2011 Dec;55(12):5790-7. doi: 10.1128/AAC.05044-11. Epub 2011 Sep 26.
2
New rules for clinical trials of patients with acute bacterial skin and skin-structure infections: do not let the perfect be the enemy of the good.急性细菌性皮肤和皮肤结构感染患者临床试验的新规则:不要让完美成为美好事物的敌人。
Clin Infect Dis. 2011 Jun;52 Suppl 7:S469-76. doi: 10.1093/cid/cir162.
3
Mol Diagn Ther. 2023 Jul;27(4):445-456. doi: 10.1007/s40291-023-00642-5. Epub 2023 Apr 11.
4
Kimyrsa, An Oritavancin-Containing Product: Clinical Study and Review of Properties.金米沙,一种含奥利万星的产品:临床研究与特性综述。
Open Forum Infect Dis. 2022 Mar 23;9(5):ofac090. doi: 10.1093/ofid/ofac090. eCollection 2022 May.
5
Hospital admissions for skin and soft tissue infections in a population with endemic scabies: A prospective study in Fiji, 2018-2019.在一个疥疮流行的人群中,因皮肤和软组织感染而住院的情况:2018-2019 年斐济的一项前瞻性研究。
PLoS Negl Trop Dis. 2020 Dec 9;14(12):e0008887. doi: 10.1371/journal.pntd.0008887. eCollection 2020 Dec.
6
Diagnostic Value of Erythrocyte Sedimentation Rate and C Reactive Protein in detecting Diabetic Foot Osteomyelitis; a Cross-sectional Study.红细胞沉降率和C反应蛋白在检测糖尿病足骨髓炎中的诊断价值;一项横断面研究。
Arch Acad Emerg Med. 2020 Sep 8;8(1):e71. eCollection 2020.
7
Ceftobiprole Activity against Bacteria from Skin and Skin Structure Infections in the United States from 2016 through 2018.2016 年至 2018 年美国皮肤和皮肤结构感染细菌的头孢托罗活性。
Antimicrob Agents Chemother. 2020 May 21;64(6). doi: 10.1128/AAC.02566-19.
8
Analysis of Pooled Phase III Efficacy Data for Delafloxacin in Acute Bacterial Skin and Skin Structure Infections.急性细菌性皮肤和皮肤结构感染中多相 III 期疗效数据的分析。
Clin Infect Dis. 2019 Apr 8;68(Suppl 3):S223-S232. doi: 10.1093/cid/ciz006.
9
Do Patients with Cellulitis Need to be Hospitalized? A Systematic Review and Meta-analysis of Mortality Rates of Inpatients with Cellulitis.蜂窝织炎患者是否需要住院?住院蜂窝织炎患者死亡率的系统评价和荟萃分析。
J Gen Intern Med. 2018 Sep;33(9):1553-1560. doi: 10.1007/s11606-018-4546-z. Epub 2018 Jul 18.
10
Evaluation of Physician Prescribing Patterns For Antibiotics in the Treatment of Nonnecrotizing Skin and Soft Tissue Infections.评估医生使用抗生素治疗非坏死性皮肤和软组织感染的处方模式。
P T. 2018 May;43(5):287-292.
Randomized controlled trial of cephalexin versus clindamycin for uncomplicated pediatric skin infections.头孢氨苄与克林霉素治疗儿童单纯性皮肤感染的随机对照试验。
Pediatrics. 2011 Mar;127(3):e573-80. doi: 10.1542/peds.2010-2053. Epub 2011 Feb 21.
4
Skin and soft tissue infections in hospitalised patients with diabetes: culture isolates and risk factors associated with mortality, length of stay and cost.住院糖尿病患者的皮肤和软组织感染:与死亡率、住院时间和费用相关的培养分离物和危险因素。
Diabetologia. 2010 May;53(5):914-23. doi: 10.1007/s00125-010-1672-5. Epub 2010 Feb 10.
5
Surgical site infections: Causative pathogens and associated outcomes.手术部位感染:病原体及相关结果。
Am J Infect Control. 2010 Mar;38(2):112-20. doi: 10.1016/j.ajic.2009.06.010. Epub 2009 Nov 3.
6
Treatment of complicated skin and soft tissue infections.治疗复杂性皮肤及软组织感染。
Surg Infect (Larchmt). 2009 Oct;10(5):467-99. doi: 10.1089/sur.2009.012.
7
Epidemiology and outcomes of hospitalizations with complicated skin and skin-structure infections: implications of healthcare-associated infection risk factors.住院治疗伴有复杂性皮肤和皮肤结构感染的流行病学和结果:医疗保健相关感染危险因素的影响。
Infect Control Hosp Epidemiol. 2009 Dec;30(12):1203-10. doi: 10.1086/648083.
8
The value of a wound score for diabetic foot infections in predicting treatment outcome: a prospective analysis from the SIDESTEP trial.伤口评分对糖尿病足感染治疗结局的预测价值:SIDESTEP试验的前瞻性分析
Wound Repair Regen. 2009 Sep-Oct;17(5):671-7. doi: 10.1111/j.1524-475X.2009.00521.x. Epub 2009 Aug 11.
9
Outcomes associated with initial versus later vancomycin use in patients with complicated skin and skin-structure infections.复杂皮肤及皮肤结构感染患者初始使用与延迟使用万古霉素的相关结局。
Pharmacoeconomics. 2009;27(5):421-30. doi: 10.2165/00019053-200927050-00006.
10
Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream.外用与全身抗菌疗法治疗轻度感染的糖尿病足溃疡:pexiganan乳膏的一项随机、对照、双盲、多中心试验
Clin Infect Dis. 2008 Dec 15;47(12):1537-45. doi: 10.1086/593185.